Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Propofol × Gynecologic × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Gynecologic 1 CNS 1

Conditions

Neoplasms 1 Endometrial Neoplasms 1 Agnosia 1

Interventions

Paclitaxel 17 Carboplatin 17 Radiotherapy 11 Cisplatin 10 Bevacizumab 8 olaparib 6 Taxes 6 Cyclophosphamide 6 pembrolizumab 5 Biopsy 5 niraparib 4 aldesleukin 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 talazoparib 3 fludarabine 3 dostarlimab 3 Radiation 3 Metformin 3 Letrozole 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Fulvestrant 3 Doxorubicin 3 Colposcopy 3 veliparib 2 palbociclib 2 liposomal doxorubicin 2 eribulin 2 balstilimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡